Indapta Therapeutics

Indapta Therapeutics is a biotechnology company, which is focused on developing and a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer. It has developed allogeneic FcRγ-deficient natural killer cells, which are known as G-NK cells. The company is focused on the treatment of hematologic and solid cancers using the immune system.